Kos, Barr Settle Niaspan Patent Litigation With Unusual Deal
Barr Pharmaceuticals Inc. and Kos Pharmaceuticals Inc. have penned an unusual settlement agreement to put an end to their patent litigation over Kos' cholesterol lowering drugs Niaspan and Advicor, the two...To view the full article, register now.
Already a subscriber? Click here to view full article